S&P 500   4,577.21 (+0.85%)
DOW   35,174.63 (+1.72%)
QQQ   383.81 (+0.18%)
AAPL   165.77 (+2.43%)
MSFT   322.63 (-0.12%)
FB   314.29 (+2.43%)
GOOGL   2,837.20 (-0.10%)
AMZN   3,414.38 (+0.73%)
TSLA   982.80 (-3.17%)
NVDA   293.67 (-4.32%)
BABA   120.23 (+7.39%)
NIO   32.19 (+0.12%)
CGC   10.02 (+0.30%)
AMD   136.48 (-5.23%)
GE   96.30 (+3.81%)
MU   81.88 (+0.32%)
T   23.72 (+1.11%)
F   19.28 (+0.73%)
DIS   150.35 (+2.82%)
PFE   52.46 (-3.34%)
AMC   29.05 (+0.14%)
ACB   5.91 (+1.55%)
BA   206.10 (+3.83%)
S&P 500   4,577.21 (+0.85%)
DOW   35,174.63 (+1.72%)
QQQ   383.81 (+0.18%)
AAPL   165.77 (+2.43%)
MSFT   322.63 (-0.12%)
FB   314.29 (+2.43%)
GOOGL   2,837.20 (-0.10%)
AMZN   3,414.38 (+0.73%)
TSLA   982.80 (-3.17%)
NVDA   293.67 (-4.32%)
BABA   120.23 (+7.39%)
NIO   32.19 (+0.12%)
CGC   10.02 (+0.30%)
AMD   136.48 (-5.23%)
GE   96.30 (+3.81%)
MU   81.88 (+0.32%)
T   23.72 (+1.11%)
F   19.28 (+0.73%)
DIS   150.35 (+2.82%)
PFE   52.46 (-3.34%)
AMC   29.05 (+0.14%)
ACB   5.91 (+1.55%)
BA   206.10 (+3.83%)
S&P 500   4,577.21 (+0.85%)
DOW   35,174.63 (+1.72%)
QQQ   383.81 (+0.18%)
AAPL   165.77 (+2.43%)
MSFT   322.63 (-0.12%)
FB   314.29 (+2.43%)
GOOGL   2,837.20 (-0.10%)
AMZN   3,414.38 (+0.73%)
TSLA   982.80 (-3.17%)
NVDA   293.67 (-4.32%)
BABA   120.23 (+7.39%)
NIO   32.19 (+0.12%)
CGC   10.02 (+0.30%)
AMD   136.48 (-5.23%)
GE   96.30 (+3.81%)
MU   81.88 (+0.32%)
T   23.72 (+1.11%)
F   19.28 (+0.73%)
DIS   150.35 (+2.82%)
PFE   52.46 (-3.34%)
AMC   29.05 (+0.14%)
ACB   5.91 (+1.55%)
BA   206.10 (+3.83%)
S&P 500   4,577.21 (+0.85%)
DOW   35,174.63 (+1.72%)
QQQ   383.81 (+0.18%)
AAPL   165.77 (+2.43%)
MSFT   322.63 (-0.12%)
FB   314.29 (+2.43%)
GOOGL   2,837.20 (-0.10%)
AMZN   3,414.38 (+0.73%)
TSLA   982.80 (-3.17%)
NVDA   293.67 (-4.32%)
BABA   120.23 (+7.39%)
NIO   32.19 (+0.12%)
CGC   10.02 (+0.30%)
AMD   136.48 (-5.23%)
GE   96.30 (+3.81%)
MU   81.88 (+0.32%)
T   23.72 (+1.11%)
F   19.28 (+0.73%)
DIS   150.35 (+2.82%)
PFE   52.46 (-3.34%)
AMC   29.05 (+0.14%)
ACB   5.91 (+1.55%)
BA   206.10 (+3.83%)
NASDAQ:DCGO

DocGo Stock Forecast, Price & News

$8.87
+0.85 (+10.60%)
(As of 12/6/2021 11:36 AM ET)
Add
Compare
Today's Range
$7.85
$8.92
50-Day Range
N/A
52-Week Range
$7.14
$11.86
Volume
9,320 shs
Average Volume
147,880 shs
Market Capitalization
$887.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive DCGO News and Ratings via Email

Sign-up to receive the latest news and ratings for DocGo and its competitors with MarketBeat's FREE daily newsletter.


DocGo logo

About DocGo

Motion Acquisition Corp. has entered into a definitive merger agreement with Ambulnz Inc.

Headlines

DocGo Announces Increase in Full-Year 2021 Guidance
December 1, 2021 |  finance.yahoo.com
DocGo (NASDAQ:DCGO) Shares Gap Up After Analyst Upgrade
November 30, 2021 |  americanbankingnews.com
Barclays Initiates Coverage on DocGo (NASDAQ:DCGO)
November 30, 2021 |  americanbankingnews.com
DocGo Announces Third Quarter 2021 Results
November 17, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry
N/A
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:DCGO
Web
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$887.61 million
Optionable
Not Optionable

Company Calendar

Today
12/06/2021
Fiscal Year End
12/31/2021

MarketRank

Overall MarketRank

2.12 out of 5 stars

Medical Sector

495th out of 1,388 stocks

Analyst Opinion: 3.5Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -












DocGo (NASDAQ:DCGO) Frequently Asked Questions

Is DocGo a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for DocGo in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" DocGo stock.
View analyst ratings for DocGo
or view top-rated stocks.

What guidance has DocGo issued on next quarter's earnings?

DocGo issued an update on its FY 2021 earnings guidance on Wednesday, December, 1st. The company provided EPS guidance of for the period. The company issued revenue guidance of $290 million-$300 million, compared to the consensus revenue estimate of $260.53 million.

What price target have analysts set for DCGO?

2 equities research analysts have issued twelve-month price objectives for DocGo's shares. Their forecasts range from $14.00 to $22.00. On average, they expect DocGo's stock price to reach $18.00 in the next twelve months. This suggests a possible upside of 102.0% from the stock's current price.
View analysts' price targets for DocGo
or view top-rated stocks among Wall Street analysts.

What is DocGo's stock symbol?

DocGo trades on the NASDAQ under the ticker symbol "DCGO."

How do I buy shares of DocGo?

Shares of DCGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is DocGo's stock price today?

One share of DCGO stock can currently be purchased for approximately $8.91.

How much money does DocGo make?

DocGo has a market capitalization of $891.61 million.


This page was last updated on 12/6/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.